Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Melanotan II structure

Melanotan II

Cosmetic & Sexual
Phase 1 Research
30%
Moderate Risk
3/5

Warnings

Not FDA approved
Risk of mole changes
Monitor existing moles for changes
High nausea potential

Contraindications

PregnancyBreastfeedingMelanoma HistoryAtypical MolesSkin Cancer History

Possible Side Effects

NauseaFacial FlushingFatigueDarkening Of MolesSpontaneous ErectionsAppetite Suppression

Legal & Regulatory

FDA Status Research Only
WADA Status Not Prohibited
Prescription Not Required

Pregnancy

Category X - Contraindicated